NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to fund efforts to develop new resources that investigators focused on pharmacogenomics can use to speed up their research activities or to implement them into practice.

The National Institutes of Health said in a funding announcement today that these enabling resources will provide activities, services, platforms, or methods that meet specific scientific needs and will benefit the entire pharmacogenomics research field.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."